Hercules Technology Growth Capital (HTGC) 12.63 $HTGC
Is Citigroup (C) Divesting Analytics Business 'Yield Book'?
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 3:15PM CDT
Wall Street banking giant Citigroup Inc. (C) continued with its strategy of divesting parts of its consumer and investment banking operations to free up capital, reduce expenses and in turn increase profits.
GLAD: 7.82 (+0.02), HTGC: 12.63 (+0.04), FMBI: 18.35 (+0.02), C: 43.33 (-0.11)
Hercules Provides Portfolio Update for Q2 2016 and Highlights Continued Execution of Its Portfolio and Earnings Growth Strategy
BusinessWire - Tue Jul 05, 10:34AM CDT
--Over $6.0 Billion in Total Debt Commitments Milestone achieved (since inception December 2003)
CPXX: 30.24 (unch), HTGC: 12.63 (+0.04), GCI: 14.13 (-0.07), PFE: 36.31 (+0.07), JAZZ: 141.39 (-0.87), ANAC: 99.06 (-0.14), RLOC: 4.58 (+0.02), EACQ: 9.80 (-0.07)
Hercules Issues Additional $9.0 Million in Principal of 6.25% Notes Due 2024 to Cover Underwriters Over-Allotment Option
BusinessWire - Tue Jul 05, 9:36AM CDT
Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"
today announced that in connection with the recent public offering of $60.0 million in aggregate principal amount of 6.25% notes due 2024 (the "Existing Notes", the underwriters exercised their option to purchase an additional $9.0 million in aggregate principal amount of 6.25% notes due 2024 (the "Notes" to cover over-allotments. The transaction closed on July 5, 2016, bringing the total size of the offering to $69.0 million.
HTGC: 12.63 (+0.04)
Aprecia Pharmaceuticals Secures up to $30 Million from Hercules Capital
PR Newswire - Tue Jul 05, 7:00AM CDT
Aprecia Pharmaceuticals Company (Aprecia), a commercial stage pharmaceutical company developing, manufacturing and marketing fast melt formulations of high dose pharmaceuticals, today announced that it has entered into an up to $30 million debt financing agreement with Hercules Capital, Inc.. Aprecia manufactures its products using its proprietary ZipDose® technology platform, that utilizes three dimensional printing (3DP) to formulate fast melt pharmaceutical products, which incorporates significantly higher amounts of active pharmaceutical ingredient than any other fast melt technology on the market.
HTGC: 12.63 (+0.04)
Hercules Prices an Additional $60.0 Million of 6.25% Notes Due 2024
BusinessWire - Thu Jun 23, 5:00AM CDT
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company" announced the pricing of an underwritten public offering of an additional $60.0 million in aggregate principal amount of its 6.25% unsecured notes due 2024 (the "Notes". The Notes constitute a further issuance of, rank equally in right of payment with, and form a single series with the $175.9 million in aggregate principal amount of the 6.25% unsecured notes due 2024 that the Company issued on July 14, 2014 and May 2, 2016, respectively (the "Existing Notes".
HTGC: 12.63 (+0.04)
Flowonix Medical, Inc. Completes $15.5 Million Financing
PR Newswire - Wed Jun 01, 4:16PM CDT
Flowonix Medical, Inc., a medical device company focused on providing advanced, implantable drug delivery solutions, announced today that it has obtained financing totaling approximately $15.5 million.
HTGC: 12.63 (+0.04)
Hercules Capital (HTGC) Posts In-Line Q1 Earnings, Up Y/Y
Zacks Equity Research - Zacks Investment Research - Fri May 06, 6:16AM CDT
Hercules Capital's first-quarter 2016 net investment income of 28 cents per share was in line with the Zacks Consensus Estimate. Also, the figure compared favorably with the year-ago tally of 20 cents.
HTGC: 12.63 (+0.04), ARCC: 14.21 (unch), GARS: 10.51 (unch), FSIC: 9.18 (-0.09)
Willis Towers (WLTW) Q1 Earnings: Stock to Disappoint?
Zacks Equity Research - Zacks Investment Research - Wed May 04, 9:55AM CDT
Willis Towers Watson Public Limited Company (WLTW) is set to report first-quarter 2016 results on May 6, before the market opens.
HTGC: 12.63 (+0.04), WLTW: 126.42 (-0.78), HPP: 30.83 (+0.52), FDUS: 15.51 (-0.07)
Hercules Closes Public Offering of $65.4 Million and $7.5 Million Over-allotment of 6.25% Notes Due 2024
BusinessWire - Tue May 03, 5:00AM CDT
--6.25% Notes due 2024 assigned BBB- rating by Standard & Poor's Ratings Services and BBB+ by Kroll Bond Rating Agency
HTGC: 12.63 (+0.04)
Hercules Receives Investment Grade Credit Rating From Standard & Poor's on Its Family of Unsecured Notes
BusinessWire - Thu Apr 28, 5:00AM CDT
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company" today announced that Standard & Poor's Ratings Services ("S&P" has assigned a BBB- rating to the following Hercules unsecured notes: 6.25% Notes due July 2024; 7.00% Notes due April 2019; and, 7.00% Notes due September 2019. This rating will also cover the additional $65.4 million in aggregate principal amount of 6.25% Notes due July 2024 which the Company expects to issue on May 2, 2016 pursuant to an underwritten public offering. S&P issued a statement announcing the credit rating and stable outlook in conjunction with the recent additional offering of the 6.25% Notes due July 2024, and subsequently assigned a BBB- credit rating to both the 7.00% Notes.
HTGC: 12.63 (+0.04)
FuelCell Energy Closes $25 million Loan Facility
GlobeNewswire - Mon Apr 18, 7:30AM CDT
FuelCell Energy, Inc. (Nasdaq:FCEL), a global leader in the design, manufacture, operation and service of ultraâ?clean, efficient and reliable fuel cell power plants, today announced that it has closed a long-term loan facility with Hercules Capital, Inc. (NYSE:HTGC) for up to $25 million to support the development of fuel cell projects. FuelCell Energy drew the first tranche of $15 million at closing. Up to an additional $10 million may be advanced under two subsequent tranches as FuelCell Energy attains certain performance and financial milestones.
FCEL: 5.31 (-0.08), HTGC: 12.63 (+0.04)
Hercules Announces Date for Release of First Quarter 2016 Financial Results and Conference Call
BusinessWire - Thu Apr 14, 5:00AM CDT
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company", the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that it has scheduled its first quarter 2016 financial results conference call for Thursday, May 5, 2016, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day.
HTGC: 12.63 (+0.04)
Hercules Continues to Expand Its Wells Fargo Accordion Credit Facility with an Additional $25 Million from EverBank
BusinessWire - Fri Apr 08, 5:00AM CDT
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company" the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced that effective April 7, 2016, it has expanded its credit facility with Wells Fargo Capital Finance ("WFCF", part of Wells Fargo & Company (NYSE:WFC), under which EverBank has committed $25.0 million, for a total of $120.0 million in credit capacity under a $300.0 million accordion credit facility, subject to borrowing base, leverage and other restrictions. Borrowings under the enhancement maintain the current interest rate of LIBOR plus 3.25% with no floor and a maturity date to August 2018, plus a 12-month amortization period. The advance rate of 50% against eligible loans remains the same.
HTGC: 12.63 (+0.04), WFC: 48.27 (-0.08)
Hercules Expands Wells Fargo Credit Facility With an Additional $20 Million From AloStar Bank of Commerce
BusinessWire - Tue Mar 08, 5:00AM CST
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company" the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced that effective March 8, 2016, it has expanded its credit facility with Wells Fargo Capital Finance ("WFCF", part of Wells Fargo & Company (NYSE:WFC), under which AloStar Bank of Commerce has committed $20.0 million, for a total of $95.0 million in credit capacity under a $300.0 million accordion credit facility, subject to borrowing base, leverage and other restrictions. Borrowings under the enhancement maintain the current interest rate of LIBOR plus 3.25% with no floor and a maturity date to August 2018, plus a 12-month amortization period. The advance rate of 50% against eligible loans remains the same.
HTGC: 12.63 (+0.04), WFC: 48.27 (-0.08)
Hercules Strengthens Senior Leadership Team with Appointment of Jennifer McKay as Vice President of Human Resources
BusinessWire - Thu Mar 03, 5:00AM CST
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company", the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, is pleased to announce the appointment of Jennifer McKay as Vice President of Human Resources.
HTGC: 12.63 (+0.04)
Hercules Announces Date for Release of Fourth Quarter and Full-Year 2015 Financial Results and Conference Call
BusinessWire - Thu Feb 04, 5:00AM CST
Hercules Technology Growth Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company", the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that it has scheduled its fourth quarter and full-year 2015 financial results conference call for Thursday, February 25, 2016, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day.
HTGC: 12.63 (+0.04)
Poxel Appoints Janice Bourque and Pierre Legault to its Board of Directors
BusinessWire - Mon Feb 01, 1:00AM CST
POXEL SA (Euronext - POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative drugs to treat type 2 diabetes, today announced the addition of Janice Bourque, Managing Director of Hercules Technology Growth Capital, and Pierre Legault, President and CEO of Nephrogenex Inc, to its Board of Directors. Both appointments were approved by Poxel's shareholders at the Annual Shareholder Meeting held in Paris last Friday, January 29, 2016.
HTGC: 12.63 (+0.04)
Downgrade Alert for Hercules Technology Growth Capital (HTGC)
Comtex SmarTrend(R) - Thu Jan 28, 7:32AM CST
Hercules Technology Growth Capital (NASDAQ:HTGC) was downgraded from Buy to Neutral at Compass Point today. The stock closed yesterday at $10.80 on volume of 248,000 shares, below average daily volume of 460,000. Hercules Technology Growth Capital has overhead space with shares priced $10.80, or 21.9% below the average consensus analyst price target of $13.83. The stock should run into initial resistance at its 50-day moving average (MA) of $11.47 and subsequent resistance at its 200-day MA of $11.73.
HTGC: 12.63 (+0.04)
Is Citigroup (C) Divesting Analytics Business 'Yield Book'?
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 3:15PM CDT
Wall Street banking giant Citigroup Inc. (C) continued with its strategy of divesting parts of its consumer and investment banking operations to free up capital, reduce expenses and in turn increase profits.
GLAD: 7.82 (+0.02), HTGC: 12.63 (+0.04), FMBI: 18.35 (+0.02), C: 43.33 (-0.11)
Hercules Provides Portfolio Update for Q2 2016 and Highlights Continued Execution of Its Portfolio and Earnings Growth Strategy
BusinessWire - Tue Jul 05, 10:34AM CDT
--Over $6.0 Billion in Total Debt Commitments Milestone achieved (since inception December 2003)
CPXX: 30.24 (unch), HTGC: 12.63 (+0.04), GCI: 14.13 (-0.07), PFE: 36.31 (+0.07), JAZZ: 141.39 (-0.87), ANAC: 99.06 (-0.14), RLOC: 4.58 (+0.02), EACQ: 9.80 (-0.07)
Hercules Issues Additional $9.0 Million in Principal of 6.25% Notes Due 2024 to Cover Underwriters Over-Allotment Option
BusinessWire - Tue Jul 05, 9:36AM CDT
Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"
today announced that in connection with the recent public offering of $60.0 million in aggregate principal amount of 6.25% notes due 2024 (the "Existing Notes", the underwriters exercised their option to purchase an additional $9.0 million in aggregate principal amount of 6.25% notes due 2024 (the "Notes" to cover over-allotments. The transaction closed on July 5, 2016, bringing the total size of the offering to $69.0 million. HTGC: 12.63 (+0.04)
Aprecia Pharmaceuticals Secures up to $30 Million from Hercules Capital
PR Newswire - Tue Jul 05, 7:00AM CDT
Aprecia Pharmaceuticals Company (Aprecia), a commercial stage pharmaceutical company developing, manufacturing and marketing fast melt formulations of high dose pharmaceuticals, today announced that it has entered into an up to $30 million debt financing agreement with Hercules Capital, Inc.. Aprecia manufactures its products using its proprietary ZipDose® technology platform, that utilizes three dimensional printing (3DP) to formulate fast melt pharmaceutical products, which incorporates significantly higher amounts of active pharmaceutical ingredient than any other fast melt technology on the market.
HTGC: 12.63 (+0.04)
Hercules Prices an Additional $60.0 Million of 6.25% Notes Due 2024
BusinessWire - Thu Jun 23, 5:00AM CDT
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"
announced the pricing of an underwritten public offering of an additional $60.0 million in aggregate principal amount of its 6.25% unsecured notes due 2024 (the "Notes". The Notes constitute a further issuance of, rank equally in right of payment with, and form a single series with the $175.9 million in aggregate principal amount of the 6.25% unsecured notes due 2024 that the Company issued on July 14, 2014 and May 2, 2016, respectively (the "Existing Notes". HTGC: 12.63 (+0.04)
Flowonix Medical, Inc. Completes $15.5 Million Financing
PR Newswire - Wed Jun 01, 4:16PM CDT
Flowonix Medical, Inc., a medical device company focused on providing advanced, implantable drug delivery solutions, announced today that it has obtained financing totaling approximately $15.5 million.
HTGC: 12.63 (+0.04)
Hercules Capital (HTGC) Posts In-Line Q1 Earnings, Up Y/Y
Zacks Equity Research - Zacks Investment Research - Fri May 06, 6:16AM CDT
Hercules Capital's first-quarter 2016 net investment income of 28 cents per share was in line with the Zacks Consensus Estimate. Also, the figure compared favorably with the year-ago tally of 20 cents.
HTGC: 12.63 (+0.04), ARCC: 14.21 (unch), GARS: 10.51 (unch), FSIC: 9.18 (-0.09)
Willis Towers (WLTW) Q1 Earnings: Stock to Disappoint?
Zacks Equity Research - Zacks Investment Research - Wed May 04, 9:55AM CDT
Willis Towers Watson Public Limited Company (WLTW) is set to report first-quarter 2016 results on May 6, before the market opens.
HTGC: 12.63 (+0.04), WLTW: 126.42 (-0.78), HPP: 30.83 (+0.52), FDUS: 15.51 (-0.07)
Hercules Closes Public Offering of $65.4 Million and $7.5 Million Over-allotment of 6.25% Notes Due 2024
BusinessWire - Tue May 03, 5:00AM CDT
--6.25% Notes due 2024 assigned BBB- rating by Standard & Poor's Ratings Services and BBB+ by Kroll Bond Rating Agency
HTGC: 12.63 (+0.04)
Hercules Receives Investment Grade Credit Rating From Standard & Poor's on Its Family of Unsecured Notes
BusinessWire - Thu Apr 28, 5:00AM CDT
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"
today announced that Standard & Poor's Ratings Services ("S&P" has assigned a BBB- rating to the following Hercules unsecured notes: 6.25% Notes due July 2024; 7.00% Notes due April 2019; and, 7.00% Notes due September 2019. This rating will also cover the additional $65.4 million in aggregate principal amount of 6.25% Notes due July 2024 which the Company expects to issue on May 2, 2016 pursuant to an underwritten public offering. S&P issued a statement announcing the credit rating and stable outlook in conjunction with the recent additional offering of the 6.25% Notes due July 2024, and subsequently assigned a BBB- credit rating to both the 7.00% Notes. HTGC: 12.63 (+0.04)
FuelCell Energy Closes $25 million Loan Facility
GlobeNewswire - Mon Apr 18, 7:30AM CDT
FuelCell Energy, Inc. (Nasdaq:FCEL), a global leader in the design, manufacture, operation and service of ultraâ?clean, efficient and reliable fuel cell power plants, today announced that it has closed a long-term loan facility with Hercules Capital, Inc. (NYSE:HTGC) for up to $25 million to support the development of fuel cell projects. FuelCell Energy drew the first tranche of $15 million at closing. Up to an additional $10 million may be advanced under two subsequent tranches as FuelCell Energy attains certain performance and financial milestones.
FCEL: 5.31 (-0.08), HTGC: 12.63 (+0.04)
Hercules Announces Date for Release of First Quarter 2016 Financial Results and Conference Call
BusinessWire - Thu Apr 14, 5:00AM CDT
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"
, the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that it has scheduled its first quarter 2016 financial results conference call for Thursday, May 5, 2016, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. HTGC: 12.63 (+0.04)
Hercules Continues to Expand Its Wells Fargo Accordion Credit Facility with an Additional $25 Million from EverBank
BusinessWire - Fri Apr 08, 5:00AM CDT
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"
the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced that effective April 7, 2016, it has expanded its credit facility with Wells Fargo Capital Finance ("WFCF", part of Wells Fargo & Company (NYSE:WFC), under which EverBank has committed $25.0 million, for a total of $120.0 million in credit capacity under a $300.0 million accordion credit facility, subject to borrowing base, leverage and other restrictions. Borrowings under the enhancement maintain the current interest rate of LIBOR plus 3.25% with no floor and a maturity date to August 2018, plus a 12-month amortization period. The advance rate of 50% against eligible loans remains the same. HTGC: 12.63 (+0.04), WFC: 48.27 (-0.08)
Hercules Expands Wells Fargo Credit Facility With an Additional $20 Million From AloStar Bank of Commerce
BusinessWire - Tue Mar 08, 5:00AM CST
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"
the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced that effective March 8, 2016, it has expanded its credit facility with Wells Fargo Capital Finance ("WFCF", part of Wells Fargo & Company (NYSE:WFC), under which AloStar Bank of Commerce has committed $20.0 million, for a total of $95.0 million in credit capacity under a $300.0 million accordion credit facility, subject to borrowing base, leverage and other restrictions. Borrowings under the enhancement maintain the current interest rate of LIBOR plus 3.25% with no floor and a maturity date to August 2018, plus a 12-month amortization period. The advance rate of 50% against eligible loans remains the same. HTGC: 12.63 (+0.04), WFC: 48.27 (-0.08)
Hercules Strengthens Senior Leadership Team with Appointment of Jennifer McKay as Vice President of Human Resources
BusinessWire - Thu Mar 03, 5:00AM CST
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"
, the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, is pleased to announce the appointment of Jennifer McKay as Vice President of Human Resources. HTGC: 12.63 (+0.04)
Hercules Announces Date for Release of Fourth Quarter and Full-Year 2015 Financial Results and Conference Call
BusinessWire - Thu Feb 04, 5:00AM CST
Hercules Technology Growth Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"
, the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that it has scheduled its fourth quarter and full-year 2015 financial results conference call for Thursday, February 25, 2016, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. HTGC: 12.63 (+0.04)
Poxel Appoints Janice Bourque and Pierre Legault to its Board of Directors
BusinessWire - Mon Feb 01, 1:00AM CST
POXEL SA (Euronext - POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative drugs to treat type 2 diabetes, today announced the addition of Janice Bourque, Managing Director of Hercules Technology Growth Capital, and Pierre Legault, President and CEO of Nephrogenex Inc, to its Board of Directors. Both appointments were approved by Poxel's shareholders at the Annual Shareholder Meeting held in Paris last Friday, January 29, 2016.
HTGC: 12.63 (+0.04)
Downgrade Alert for Hercules Technology Growth Capital (HTGC)
Comtex SmarTrend(R) - Thu Jan 28, 7:32AM CST
Hercules Technology Growth Capital (NASDAQ:HTGC) was downgraded from Buy to Neutral at Compass Point today. The stock closed yesterday at $10.80 on volume of 248,000 shares, below average daily volume of 460,000. Hercules Technology Growth Capital has overhead space with shares priced $10.80, or 21.9% below the average consensus analyst price target of $13.83. The stock should run into initial resistance at its 50-day moving average (MA) of $11.47 and subsequent resistance at its 200-day MA of $11.73.
HTGC: 12.63 (+0.04)
